Cadrenal Therapeutics Management
Management criteria checks 1/4
Cadrenal Therapeutics' CEO is Quang Pham, appointed in Jan 2022, has a tenure of 2.75 years. total yearly compensation is $967.00K, comprised of 68.5% salary and 31.5% bonuses, including company stock and options. directly owns 39.2% of the company’s shares, worth $6.82M. The average tenure of the management team and the board of directors is 2.3 years and 1.8 years respectively.
Key information
Quang Pham
Chief executive officer
US$967.0k
Total compensation
| CEO salary percentage | 68.5% |
| CEO tenure | 2.8yrs |
| CEO ownership | 39.2% |
| Management average tenure | 2.3yrs |
| Board average tenure | 1.8yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$6m |
| Mar 31 2024 | n/a | n/a | -US$5m |
| Dec 31 2023 | US$967k | US$663k | -US$8m |
| Sep 30 2023 | n/a | n/a | -US$13m |
| Jun 30 2023 | n/a | n/a | -US$13m |
| Mar 31 2023 | n/a | n/a | -US$12m |
| Dec 31 2022 | US$822k | US$350k | -US$7m |
Compensation vs Market: Quang's total compensation ($USD967.00K) is above average for companies of similar size in the US market ($USD661.09K).
Compensation vs Earnings: Quang's compensation has increased whilst the company is unprofitable.
CEO
Quang Pham (59 yo)
2.8yrs
Tenure
US$967,000
Compensation
Mr. Quang X. Pham Founded Lathian Health, Inc. (Formerly known as MyDrugRep, Inc.) in January 2000 and also serves as its Chief Executive Officer. He is a Director at Cognition Therapeutics, Inc. since Oct...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 2.8yrs | US$967.00k | 39.2% $ 6.8m | |
| Co-Founder & CFO | 2.4yrs | US$844.89k | 3.12% $ 543.3k | |
| Chief Medical Officer | 2.2yrs | US$528.69k | 0% $ 0 | |
| Chief Operating Officer | less than a year | no data | no data |
2.3yrs
Average Tenure
59yo
Average Age
Experienced Management: CVKD's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | no data | US$967.00k | 39.2% $ 6.8m | |
| Independent Director | 1.8yrs | US$35.00k | 0.31% $ 54.3k | |
| Independent Director | 1.8yrs | US$35.00k | 0.25% $ 43.5k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 1.8yrs | US$50.00k | 3.84% $ 668.1k | |
| Independent Director | 1.3yrs | US$74.50k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
1.8yrs
Average Tenure
65yo
Average Age
Experienced Board: CVKD's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.